ClinicalTrials.gg
Drug

Zavegepant clinical trials

Also written BHV3500.

studies test it
18
open now
5
in phase 3
7
first study started
2019

How each study uses zavegepant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the zavegepant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Mar 2023 · ZAVZPRET · NDA 216386 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zavegepant
9
Zavegepant (BHV-3500)
2

Brand

Zavzpret
1

Development codes

BHV3500
3
PF-07930207
1

Other names

Vazegepant
1

Studies by the year they started

18 studies that test it; most in 2020 (3)

Studies that test zavegepant, by start year
YearStudies
20191
20203
20212
20221
20233
20242
20253
20263

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
5
Phase 3
7
Phase 4
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 5

Pfizer (13) · American Center for Psychiatry and Neurology (1) · The University of Texas Health Science Center, Houston (1) · University of South Florida (1) · Mayo Clinic (1) · Icahn School of Medicine at Mount Sinai (1)

Often tested with

Tested in the same studies.

Rimegepant (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test zavegepant.

Studies

Open first, then newest update. How each study uses zavegepant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call zavegepant · ClinicalTrials.gg INT006389

  • MeSH (NLM) C584752zavegepantOne source NLM
  • UNII (FDA) ODU3ZAZ94JZAVEGEPANTConfirmed FDA, NLM, Wikidata
  • Wikidata Q99388898zavegepantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C172616ZavegepantOne source FDA
  • DrugBank DB15688One source Wikidata

Also registered as zavegepant hydrochloride (UNII 000QCM6HAL).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.